Sell Bank of Americ...
Health Care: Drugs
Neurobiological Technologies Incorporated (NTII: OTC)
$0.12 -0.02 | -13.79%
02/10/12 - 01:41 PM ET
1.00K / 287.00K
Vol / Avg. Vol:0.12 / 0.14
Open / Prev. Close:0.12 - 0.12
Today's Range:0.06 - 0.16
52 Wk Range:-39.13%
Performance YTD:TheStreet Rating:
Portfolios with NTII
- Portfolio NameUser Type
- ContributorBarron's Activist Stocks 1-...
- UserBarron's Research Reports 1...
- UserJamie F's personal portfolio
- UserJC's Mismanaged Portfolio
- Userstock list # one
- Userarmygrunt Portfolio 1
- UserPANTERA GROUP 47
- Useraal Portfolio 1
- Userfall test
- UserFall
Latest NTII Headlines from TheStreet
- Friday's Health Winners & Losers 06.16.06 | 02:06 pm
- Health Stocks in Motion 09.20.05 | 02:09 pm
- Vaso Active, Millennium Find Common Ground 03.18.04 | 11:03 am
- Brain Drug Invigorating Once-Moribund NTI 08.22.00 | 12:08 pm
Press Releases for NTII
- Celtic Pharma Announces Initiation Of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) In Pediatric Patients With Primary And Metastatic Brain Tumors - PR Newswire 04.22.10 | 08:04 am
- Neurobiological Technologies Announces Extraordinary Dividend Of $0.18 Per Share - PR Newswire 11.23.09 | 08:11 am
Partner Headlines for NTII
